Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.225ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
BA.5.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.201ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.304ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.577ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.577ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.639ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.639ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.308ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used